Hide filtersShow filters × Close 80% of Kippr acquired by ECIT AS MakeIt Drift as acquired by Procano AS Bryan, Garnier & Co acts as Joint Bookrunner on Materialise’s USD45 million Follow–On Equity Offering on Nasdaq Bryan, Garnier & Co advises TxCell in its strategic review and subsequent EUR72 million sale to Sangamo Therapeutics to create a CAR-Treg leader Bryan, Garnier & Co acts as Sole Bookrunner on ASIT biotech EUR12 million Convertible Bond Placement Bryan, Garnier & Co advises Marquetis & Co and its management on a sponsorless operation with Omnes Private Placement OncoImmunity AS Bryan, Garnier & Co acts as Co-manager on Canopy Growth’s benchmark CAD600 million Convertible Bond New Issue Bryan, Garnier & Co advises Picturae on its sale to Karmijn – contributing to the preservation of cultural heritage Private Placement BRABank ASA Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner for Voluntis’ IPO, the first ever listing of a digital therapeutics company raising EUR30.1 million Bryan, Garnier & Co acts as Lead Manager on Medigene’s EUR48.3 million offering
